BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8188476)

  • 1. A new vitreal drug delivery system using an implantable biodegradable polymeric device.
    Kimura H; Ogura Y; Hashizoe M; Nishiwaki H; Honda Y; Ikada Y
    Invest Ophthalmol Vis Sci; 1994 May; 35(6):2815-9. PubMed ID: 8188476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Intravitreal drug delivery by microspheres of biodegradable polymers].
    Moritera T; Ogura Y; Honda Y; Wada R; Hyon SH; Ikada Y
    Nippon Ganka Gakkai Zasshi; 1990 May; 94(5):508-13. PubMed ID: 2220493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implantable biodegradable polymeric device in the treatment of experimental proliferative vitreoretinopathy.
    Hashizoe M; Ogura Y; Takanashi T; Kunou N; Honda Y; Ikada Y
    Curr Eye Res; 1995 Jun; 14(6):473-7. PubMed ID: 7671629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scleral plug of biodegradable polymers for controlled drug release in the vitreous.
    Hashizoe M; Ogura Y; Kimura H; Moritera T; Honda Y; Kyo M; Hyon SH; Ikada Y
    Arch Ophthalmol; 1994 Oct; 112(10):1380-4. PubMed ID: 7945044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polysulfone capillary fiber for intraocular drug delivery: in vitro and in vivo evaluations.
    Rahimy MH; Peyman GA; Chin SY; Golshani R; Aras C; Borhani H; Thompson H
    J Drug Target; 1994; 2(4):289-98. PubMed ID: 7858954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microspheres of biodegradable polymers as a drug-delivery system in the vitreous.
    Moritera T; Ogura Y; Honda Y; Wada R; Hyon SH; Ikada Y
    Invest Ophthalmol Vis Sci; 1991 May; 32(6):1785-90. PubMed ID: 2032801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clearance of sodium fluorescein incorporated into microspheres from the vitreous after intravitreal injection.
    Khoobehi B; Stradtmann MO; Peyman GA; Aly OM
    Ophthalmic Surg; 1991 Mar; 22(3):175-80. PubMed ID: 2030905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scleral plug of biodegradable polymers containing tacrolimus (FK506) for experimental uveitis.
    Sakurai E; Nozaki M; Okabe K; Kunou N; Kimura H; Ogura Y
    Invest Ophthalmol Vis Sci; 2003 Nov; 44(11):4845-52. PubMed ID: 14578407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biodegradable polymeric device for sustained intravitreal release of ganciclovir in rabbits.
    Hashizoe M; Ogura Y; Takanashi T; Kunou N; Honda Y; Ikada Y
    Curr Eye Res; 1997 Jul; 16(7):633-9. PubMed ID: 9222079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravitreal delivery of ciprofloxacin.
    Hainsworth DP; Conklin JD; Bierly JR; Ax D; Ashton P
    J Ocul Pharmacol Ther; 1996; 12(2):183-91. PubMed ID: 8773934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel design of one-side coated biodegradable intrascleral implant for the sustained release of triamcinolone acetonide.
    Kim YM; Lim JO; Kim HK; Kim SY; Shin JP
    Eur J Pharm Biopharm; 2008 Sep; 70(1):179-86. PubMed ID: 18667297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biodegradable chitosan and polylactic acid-based intraocular micro-implant for sustained release of methotrexate into vitreous: analysis of pharmacokinetics and toxicity in rabbit eyes.
    Manna S; Banerjee RK; Augsburger JJ; Al-Rjoub MF; Donnell A; Correa ZM
    Graefes Arch Clin Exp Ophthalmol; 2015 Aug; 253(8):1297-305. PubMed ID: 25896109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro evaluation of polymeric matrix and porous biodegradable reservoir devices for slow-release drug delivery.
    Peyman GA; Yang D; Khoobehi B; Rahimy MH; Chin SY
    Ophthalmic Surg Lasers; 1996 May; 27(5):384-91. PubMed ID: 8860606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreous delivery of dexamethasone sodium m-sulfobenzoate from poly(DL-lactic acid) implants.
    Morita Y; Ohtori A; Kimura M; Tojo K
    Biol Pharm Bull; 1998 Feb; 21(2):188-90. PubMed ID: 9514619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biodegradable scleral implant for intravitreal controlled release of fluconazole.
    Miyamoto H; Ogura Y; Hashizoe M; Kunou N; Honda Y; Ikada Y
    Curr Eye Res; 1997 Sep; 16(9):930-5. PubMed ID: 9288455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility of drug delivery to the posterior pole of the rabbit eye with an episcleral implant.
    Kato A; Kimura H; Okabe K; Okabe J; Kunou N; Ogura Y
    Invest Ophthalmol Vis Sci; 2004 Jan; 45(1):238-44. PubMed ID: 14691179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biodegradable polymer microspheres for targeted drug delivery to the retinal pigment epithelium.
    Ogura Y; Kimura H
    Surv Ophthalmol; 1995 May; 39 Suppl 1():S17-24. PubMed ID: 7660308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraocular degradation behavior of crosslinked and linear poly(trimethylene carbonate) and poly(D,L-lactic acid).
    Jansen J; Koopmans SA; Los LI; van der Worp RJ; Podt JG; Hooymans JM; Feijen J; Grijpma DW
    Biomaterials; 2011 Aug; 32(22):4994-5002. PubMed ID: 21507481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biodegradable poly(DL-lactic acid) formulations in a calcitonin delivery system.
    Asano M; Yoshida M; Omichi H; Mashimo T; Okabe K; Yuasa H; Yamanaka H; Morimoto S; Sakakibara H
    Biomaterials; 1993 Aug; 14(10):797-9. PubMed ID: 8218732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poly-epsilon-caprolactone intravitreous devices: an in vivo study.
    Silva-Cunha A; Fialho SL; Naud MC; Behar-Cohen F
    Invest Ophthalmol Vis Sci; 2009 May; 50(5):2312-8. PubMed ID: 19117927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.